RECENT NEWS

10-07-08
Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc.

08-05-08
Arbios Announces It Has Suspended Operations

05-12-08
Arbios Receives Approval from the FDA to Initiate Pivotal Trial for SEPET™ Liver Assist Device

04-15-08
Arbios Commences Process to Seek European Marketing Approval for SEPET™

02-22-08
Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET™

10-31-07
Arbios to Present at Acumen Biofin Rodman & Renshaw 9^th Annual Healthcare Conference

10-23-07
Arbios Announces SEPET™ Manufacturing with NxStage Medical

09-25-07
Arbios Provides Clinical Strategy for SEPET™ Pivotal Trial

09-20-07
Arbios Systems Announces Exclusive Supply Agreement with Membrana GmbH for Blood Filtration Membranes

09-19-07
Arbios Announces Management Changes

09-07-07
Arbios Systems Publishes Positive Results from Completed SEPET™ Feasibility Clinical Trials

04-23-07
Arbios Raises $4.8 Million to Advance Its SEPET™ Liver Assist Device into Pivotal Clinical Trials

04-02-07
Arbios Systems Reports Favorable Results From the SEPET™ Feasibility Clinical Trial

03-30-07
Arbios Systems Strengthens Its Proprietary Position for Blood Filtration Therapies in Critical Care Medicine

01-18-07
Arbios Systems, Inc. Informational Review Issued by Scimitar Equity Research, Inc.

Terms of Use
Copyright © 2006 Arbios Systems, Inc.  All rights reserved